Orlova, K. V., Kozlov, V., Moiseyenko, V., Pokataev, I., Fedyanin, M., Shumskaya, I., Ogorodnikova, S., Zimina, A. V., Odintsova, S., Kovalenko, N. V., Penkov, K., Dziamidava, S. A., Zukov, R., Ermakov, N., Volkov, V. (2026). A phase III randomized study comparing BCD-201, a pembrolizumab biosimilar candidate, and reference pembrolizumab in patients with advanced melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9541